Individual Postprandial Glycemic Responses to Diet in n-of-1 Trials: Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR)
Open Access
- 13 July 2021
- journal article
- research article
- Published by Elsevier in The Journal of Nutrition
- Vol. 151 (10) , 3158-3167
Abstract
The role of different types and quantities of macronutrients on human health has been controversial, and the individual response to dietary macronutrient intake needs more investigation. We aimed to use an ‘n-of-1’ study design to investigate the individual variability in postprandial glycemic response when eating diets with different macronutrient distributions among apparently healthy adults. Thirty apparently healthy young Chinese adults (women, 68%) aged between 22 and 34 y, with BMI between 17.2 and 31.9 kg/m2, were provided with high-fat, low-carbohydrate (HF-LC, 60–70% fat, 15–25% carbohydrate, 15% protein, of total energy) and low-fat, high-carbohydrate (LF-HC, 10–20% fat, 65–75% carbohydrate, 15% protein) diets, for 6 d wearing continuous glucose monitoring systems, respectively, in a randomized sequence, interspersed by a 6-d wash-out period. Three cycles were conducted. The primary outcomes were the differences of maximum postprandial glucose (MPG), mean amplitude of glycemic excursions (MAGE), and AUC24 between intervention periods of LF-HC and HF-LC diets. A Bayesian model was used to predict responders with the posterior probability of any 1 of the 3 outcomes reaching a clinically meaningful difference. Twenty-eight participants were included in the analysis. Posterior probability of reaching a clinically meaningful difference of MPG (0.167 mmol/L), MAGE (0.072 mmol/L), and AUC24 (13.889 mmol/L·h) between LF-HC and HF-LC diets varied among participants, and those with posterior probability >80% were identified as high-carbohydrate responders (n = 9) or high-fat responders (n = 6). Analyses of the Bayesian-aggregated n-of-1 trials among all participants showed a relatively low posterior probability of reaching a clinically meaningful difference of the 3 outcomes between LF-HC and HF-LC diets. N-of-1 trials are feasible to characterize personal response to dietary intervention in young Chinese adults.Keywords
Funding Information
- National Natural Science Foundation of China (82073529, 81903316)
- Zhejiang Ten-thousand Talents (2019R52039)
- Zhejiang Provincial Natural Science Foundation of China (LQ21H260002)
- China Postdoctoral Science Foundation (2020M681945)
- Zhejiang Postdoctoral Science Foundation (ZJ2020076)
This publication has 38 references indexed in Scilit:
- Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocolBMC Palliative Care, 2013
- Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical TrialsDiabetes Technology & Therapeutics, 2012
- Impact of postprandial glycaemia on health and prevention of diseaseObesity Reviews, 2012
- Macronutrients, Food Groups, and Eating Patterns in the Management of DiabetesDiabetes Care, 2012
- The N-Of-1 Clinical Trial: The Ultimate Strategy For Individualizing Medicine?Personalized Medicine, 2011
- Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerationsJournal of Clinical Epidemiology, 2010
- Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic IndividualsDiabetes Care, 2010
- Variability of the glycemic response to single food products in healthy subjectsContemporary Clinical Trials, 2010
- Another approach to estimating the reliability of glycaemic indexBritish Journal of Nutrition, 2008
- Glycemic VariabilityDiabetes Care, 2008